Proteomics Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 27.60 Billion |
| Market Size (2029) | USD 41.36 Billion |
| CAGR (2024 - 2029) | 8.42 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Proteomics Market Analysis
The Proteomics Market size is estimated at USD 27.60 billion in 2024, and is expected to reach USD 41.36 billion by 2029, growing at a CAGR of 8.42% during the forecast period (2024-2029).
Certain factors driving the market growth include rising demand for personalized medicine, increasing R&D expenditure and government funding for proteomics, and technological advancements.
These major drivers will continue to drive the biopharmaceutical industry's pursuit of blockbuster drugs and the recent technological advances in the studies of genes and proteins. Alliances are becoming increasingly important in this field because it is challenging for companies to find all the necessary expertise to cover all activities involved in proteomics. For example, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies. Increased demand for personalized medicines and increased R&D in proteomics are also driving factors for the market. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
Proteomics Market Trends
This section covers the major market trends shaping the Proteomics Market according to our research experts:
Drug Discovery is Expected to Witness Healthy CAGR in Future
The identification of potential new drugs for the treatment of disease has been considered one of the most promising developments in the study of human genes and proteins. This depends on genome and proteome information for the identification of proteins, associated with a disease, which can then be used as targets for new drugs by computer software. Preclinical stages in the process of drug discovery need a multitude of genetic and biochemical assays in order to characterize the effects of drug candidates on cellular systems as well as model organisms. Almost every large pharmaceutical company now has proteomics-oriented biotech or academic partner or has started its own proteomics division. The general applications of proteomics in the drug industry include identification of efficacy and of toxicity biomarkers from readily accessible biological fluids, target identification and validation, and investigations into mechanisms of drug action or toxicity.
North America dominates the Market and expected to do Same in the Forecast Period
In North America, antibody-drug conjugates and protein therapeutics play a significant role in the treatment and diagnosis of diseases. This is a continuously evolving field with extensive research on novel and innovative next-generation therapeutics. More than a hundred modified therapeutic proteins are approved for clinical use in the region. Hundreds of protein therapeutics are in clinical trials for the treatment of cancer, immune disorders, infections, age-related diseases, and many other conditions. Besides, research on proteomics is at the highest in countries like the United States.
Proteomics Industry Overview
The global proteomics market is highly competitive and consists of a number of major players. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation, among others, hold the substantial share in the proteomics market.
Proteomics Market Leaders
-
Agilent Technologies, Inc.
-
Bio-Rad Laboratories, Inc.
-
Thermo Fisher Scientific, Inc.
-
Danaher Corporation
-
GE Healthcare
*Disclaimer: Major Players sorted in no particular order
Proteomics Market News
In Feb 2021, Agilent Technologies Inc. launched Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
In Dec 2020, Thermo Fisher Scientific, acquired Phitonex, Inc. Phitonex's product offering will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities to meet evolving customer needs in protein and cell analysis research.
Proteomics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Personalized Medicine
4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product & Services
5.1.1 Instrumentation Technology
5.1.1.1 Spectroscopy
5.1.1.2 Chromatography
5.1.1.3 Electrophoresis
5.1.1.4 Protein Microarrays
5.1.1.5 X-Ray Crystallography
5.1.1.6 Other Instrumentation Technologies
5.1.2 Reagents
5.1.3 Software and Services
5.2 By Application
5.2.1 Clinical Diagnostics
5.2.2 Drug Discovery
5.2.3 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies, Inc.
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Bruker Corporation
6.1.4 Danaher Corporation
6.1.5 GE Healthcare
6.1.6 Merck KGaA
6.1.7 Promega Corporation
6.1.8 Thermo Fisher Scientific, Inc.
6.1.9 Waters Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Proteomics Industry Segmentation
Proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.
| By Product & Services | ||||||||
| ||||||||
| Reagents | ||||||||
| Software and Services |
| By Application | |
| Clinical Diagnostics | |
| Drug Discovery | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Proteomics Market Research FAQs
How big is the Proteomics Market?
The Proteomics Market size is expected to reach USD 27.60 billion in 2024 and grow at a CAGR of 8.42% to reach USD 41.36 billion by 2029.
What is the current Proteomics Market size?
In 2024, the Proteomics Market size is expected to reach USD 27.60 billion.
Who are the key players in Proteomics Market?
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation and GE Healthcare are the major companies operating in the Proteomics Market.
Which is the fastest growing region in Proteomics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Proteomics Market?
In 2024, the North America accounts for the largest market share in Proteomics Market.
What years does this Proteomics Market cover, and what was the market size in 2023?
In 2023, the Proteomics Market size was estimated at USD 25.46 billion. The report covers the Proteomics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Proteomics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the emerging trends in the Proteomics Industry?
The emerging trends in the Proteomics Industry are a) Increased research on protein-protein interactions to understand disease mechanisms and identify novel drug targets b) Exploration of proteomics in areas like agriculture, environmental science, and food science
Proteomics Industry Report
The proteomics industry is witnessing significant growth, fueled by technological advancements that have revolutionized proteomic analyses, enhancing sensitivity, resolution, and throughput. This evolution has propelled biomarker discovery, personalized medicine, and drug development, with a surge in demand driven by the focus on personalized treatments and the increasing prevalence of diseases requiring targeted approaches. The expansion into emerging markets presents high growth opportunities, supported by advancements in proteomic technologies and government initiatives promoting research and innovation. Despite challenges like high costs and complex data management, the industry's future looks promising, playing a crucial role in advancing healthcare by deepening our understanding of diseases at the molecular level. For detailed insights, Mordor Intelligence™ offers comprehensive market share, size, and revenue growth rate statistics in their Proteomics market analysis, including a forecast outlook and historical overview. Access a free report PDF download for an in-depth industry analysis.
Proteomics Market Report Snapshots
